Seife v. FDA (S.D.N.Y) -- concluding that FDA properly relied on Exemption 4 to withhold records pertaining to its accelerated approval of a muscular dystrophy drug; noting that statute’s foreseeable harm provision applied to Exemption 4 and was met in this case.
Yanofsky v. U.S. Dep't of Commerce (D.D.C.) -- deciding that agency did not sufficiently establish that it either provided plaintiff with requested data files or that it did not maintain those files.
Summaries of all published opinions issued since April 2015 are available here.